Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells

por Hsieh, S Y, Liaw, S F, Lee, S N, Hsieh, P S, Lin, K H, Chu, C M, Liaw, Y F
Publicado 2003

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection

por Chu, C-M, Lin, C-C, Chen, Y-C, Jeng, W-J, Lin, S-M, Liaw, Y-F
Publicado 2012

Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers

por Yu, M-W, Chiu, Y-H, Yang, S-Y, Santella, R M, Chern, H-D, Liaw, Y-F, Chen, C-J
Publicado 1999

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

por Wang, Y, Thongsawat, S, Gane, E J, Liaw, Y-F, Jia, J, Hou, J, Chan, H L Y, Papatheodoridis, G, Wan, M, Niu, J, Bao, W, Trylesinski, A, Naoumov, N V
Publicado 2013